Alpha BreakingHOPE: Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment
|Monday, May 11, 2026 at 7:00 AM ET
Share this article
Spread the word on social media
Latest Updates
May 11, 10:00 AM
Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment
Studies presented as part of "The 2026 International Congress of the International Liver Transplantation Society (ILTS)" in Geneva, Switzerland, May 6-9, 2026 Presentations further support use of HOPE in U.S. and EU for making more organs available for transplantation, reducing registry...
Source: PR Newswire
May 11, 10:00 AM
Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment
Studies presented as part of "The 2026 International Congress of the International Liver Transplantation Society (ILTS)" in Geneva, Switzerland, May 6-9, 2026 Presentations further support use of HOPE in U.S. and EU for making more organs available for transplantation, reducing registry...
Source: PR Newswire